Inventor · disambiguated record
Herbert Haack
Also filed as: HAACK HERBERT
18 granted patents·13 pending applications·61 citations·filing 2007–2021
93Inventor score
Files withCELL SIGNALING TECHNOLOGY INC20RIKOVA KLARISA6GU TING LEI2RIMKUNAS VICTORIA MCGUINNESS2HAACK HERBERT1
Top patents by PatentIndex Score
31 records- 0195US7700339B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Apr 20, 2010·22 cites·15 claims
- 0292US8232060B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted Jul 31, 2012·6 cites·60 claims
- 0390US8481279B2Methods of treating lung cancer using inhibitors anaplastic lymphoma kinaseRIKOVA KLARISA·Filed 2012·Granted Jul 9, 2013·6 cites·24 claims
- 0490US8288102B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2010·Granted Oct 16, 2012·5 cites·40 claims
- 0589US8377642B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2010·Granted Feb 19, 2013·5 cites·36 claims
- 0685US10551383B2Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Feb 4, 2020·2 cites·5 claims
- 0783US8168383B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted May 1, 2012·5 cites·7 claims
- 0882US9523130B2Methods of treating non-small cell lung carcinoma (NSCLC)CELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Dec 20, 2016·1 cites·29 claims
- 0980US9988688B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jun 5, 2018·1 cites·15 claims
- 1080US8486645B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Granted Jul 16, 2013·2 cites·12 claims
- 1177US11505833B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Nov 22, 2022·0 cites·10 claims
- 1276US7833736B2Protein markers of responsiveness to type III receptor tyrosine kinase inhibitorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Nov 16, 2010·5 cites·17 claims
- 1374US2022003771A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1473US10870892B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Dec 22, 2020·0 cites·12 claims
- 1572US2020363417A1Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancerCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 1670US10955416B2Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Mar 23, 2021·0 cites·9 claims
- 1769US2022267854A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1868US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1967US2018156802A1Methods of treating lung cancer by administration of an alk inhibitorCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 2065US9364477B2Mutant ROS expression in human cancerGU TING-LEI·Filed 2010·Granted Jun 14, 2016·1 cites·24 claims
- 2164US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 2262US2014134640A1Gene Defects And Mutant ALK Kinase In Human Solid TumorsCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 2361US2013209452A1Gene defects and mutant alk kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Application pending·0 cites
- 2459US9539254B2Mutant ROS expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted Jan 10, 2017·0 cites·8 claims
- 2555US10000568B2Compositions and methods for detecting EGFR in cancerGU TING LEI·Filed 2009·Granted Jun 19, 2018·0 cites·5 claims
- 2655US2017275706A1Alk and ros kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 2755US2015056193A1Egfr and ros1 kinase in cancerCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 2854US2012101108A1Anaplastic Lymphoma Kinase In Kidney CancerHAACK HERBERT·Filed 2011·Application pending·0 cites
- 2948US2017071941A1Mutant ros expression in human cancerCELL SIGNALING TECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 3047US2012208824A1ROS Kinase in Lung CancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
- 3144US2013288240A1Alk and ros kinase in cancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herbert Haack files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →